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SUMMARY
The detection of diverse chemical structures by the
vertebrate olfactory system is accomplished by the
recognition of odorous ligands by their cognate re-
ceptors. In the present study, we used computational
screening to discover novel high-affinity agonists of
an olfactory G protein-coupled receptor that recog-
nizes amino acid ligands. Functional testing of the
top candidates validated several agonists with po-
tencies higher than any of the receptor’s known nat-
ural ligands. Computational modeling revealed mo-
lecular interactions involved in ligand binding and
further highlighted interactions that have been con-
served in evolutionarily divergent amino acid recep-
tors. Significantly, the top compounds display robust
activities as odorants in vivo and include a natural
product that may be used to signal the presence of
bacteria in the environment. Our virtual screening ap-
proach should be applicable to the identification of
new bioactive molecules for probing the structure
of chemosensory receptors and the function of che-
mosensory systems in vivo.
INTRODUCTION
The vertebrate olfactory system receives and decodes sensory
information from a myriad chemical cues. The first step in this
process is the recognition of these cues by receptors expressed
by the primary sensory neurons in the olfactory epithelium (Fire-
stein, 2001). Vertebrate olfactory receptors comprise four differ-
ent families of G protein-coupled receptors (Mombaerts, 2004)
(GPCRs): the OR receptor family, the largest family with 1000
functional members in some mammalian species (Zhang et al.,
2004); the trace amine-associated receptors (Liberles and
Buck, 2006) (TAARs; <20 members); the V1R vomeronasal re-
ceptors (Zhang et al., 2004) (150 members); and the V2R vom-
eronasal receptors (Yang et al., 2005) (60 members). The V2R
receptors belong to the C family of GPCRs, which includes the
calcium-sensing receptor (CaSR), metabotropic glutamate
(mGlu) receptors, GABA-B receptors, and T1R taste receptors
(Pin et al., 2003).
We previously identified a V2R-like receptor from the goldfish
olfactory epithelium that is activated by all 20 natural amino
acids, which are potent odorants for fish (Luu et al., 2004; Speca
et al., 1999). This receptor, called receptor 5.24, responds pref-
erentially to the long-chain basic amino acids, lysine and argi-
nine, although other amino acids can bind to this receptor with
lower affinities. This broad tuning of receptor 5.24 embodies
the promiscuous nature of the odorant receptors, a mechanism
that allows the olfactory system to recognize a diversity of chem-
ical structures exceeding the actual number of receptors en-
coded by the genome. It is therefore of great interest to elucidate
the molecular determinants of ligand selectivity—using receptor
5.24 as a prototypical receptor—in order to understand how the
olfactory/vomeronasal C family GPCRs have evolved to recog-
nize their cognate ligands.
Unlike other GPCRs, members of the C family GPCRs are
characterized by a large extracellular N-terminal domain (NTD),
the location of the orthosteric ligand binding site. The NTD
adopts a conserved clamshell-like fold—also referred to as the
Venus fly trap domain (VFTD)—with two lobes connected by
a flexible hinge. Analysis of protein crystal structures and molec-
ular modeling have identified ligand interactions with the inner
surfaces of lobes 1 and 2 that stabilize a closed conformation
of the VFTD, leading to receptor activation (reviewed by Pin
et al., 2003). An inspection of the core binding residues reveals
numerous potential contacts with ligand that can be sorted
into two groups: the ‘‘proximal’’ and ‘‘distal’’ binding pockets.
The proximal pocket residues are predicted to bind the amino
acid ligand’s glycine moiety (i.e., the a-carboxyl together with
the a-amino group and a-proton). Residues residing in the distal
pocket interact with the amino acid ligand’s side chain and are
responsible for conferring selectivity for distinct side-chainNeuron 60, 767–774, December 11, 2008 ª2008 Elsevier Inc. 767
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Novel Odorants Identified by Virtual Screeningstructures. In the case of goldfish receptor 5.24, through homol-
ogy modeling we previously identified several distal pocket
residues that can account for this receptor’s preference for
long-chain basic amino acids (Luu et al., 2004).
In the present study, we sought to utilize novel chemical struc-
tures to probe more deeply into the structure and function of the
receptor 5.24 binding pocket. We further wished to know
whether high potency agonists that were selected based on their
interactions with a single receptor would also be active in elicit-
ing olfactory responses in vivo. To this end, we developed and
applied a suite of computational techniques to screen for recep-
tor 5.24 agonists. This ‘‘virtual high-throughput screening’’
(vHTS) approach identified numerous active compounds, with
several showing significantly higher potency than any of the pre-
viously known natural ligands for this receptor. Docking of the
most active compounds in three-dimensional models of the
receptor confirmed the importance of several binding pocket
residues in determining affinity and selectivity. Interestingly,
analysis of one series of ligands reveals a conserved ligand-
stabilized helix-helix interaction in lobe 1 that is associated
with ligand recognition and receptor activation in evolutionarily
divergent amino acid receptors. Finally, electrophysiological re-
cordings from goldfish olfactory epithelium indicate that the
computationally identified agonists can indeed elicit robust re-
sponses by olfactory sensory neurons in vivo. One novel odorant
discovered, diaminopimelic acid, is a precursor in the lysine and
peptidoglycan biosynthetic pathways of bacteria, suggesting
that the fish olfactory system may use the presence of this me-
tabolite to detect bacteria in their environment. Together, these
results demonstrate the utility of our vHTS approach in identify-
ing novel compounds for probing C family GPCR structure and
function and for interrogating olfactory function in vivo.
RESULTS
Virtual Screening for the Discovery of Novel Receptor
Agonists
Elucidation of the principles underlying ligand binding and acti-
vation in the metabotropic glutamate receptors has been greatly
facilitated by an array of high affinity agonists and antagonists
(Pin et al., 1999). By analogy, we expect that the identification
of novel high-affinity ligands for receptor 5.24 will similarly pro-
vide new molecules with which to probe the structure and func-
tion of this and potentially other chemosensory C family GPCRs.
To achieve this goal, we implemented a computational screening
paradigm to search for ligands based on two independent crite-
ria: (1) chemicals that ‘‘fit’’ in the predicted ligand binding pocket
structure (structure-based vHTS) and (2) chemicals that exhibit
features identified by a pharmacophore model of activating
ligands (ligand-based vHTS). Since our vHTS approach requires
a detailed structural model of the receptor binding pocket as well
as an extensive pharmacological profile for the receptor, we
implemented this vHTS approach on goldfish receptor 5.24, for
which we already have extensive data (Luu et al., 2004).
vHTS Protocol Design and Optimization
As with any screening protocol, a balance must be found to max-
imize the identification of true positive ‘‘hits’’ while avoiding an
inordinate number of false positives. We therefore designed
the computational protocols according to the receiver operating
characteristic (ROC) curve approach, which provides an objec-
tive measure of the ability of a given screening workflow to
discriminate known active molecules from known inactive mole-
cules—a critical test of the design of any screening protocol
(Triballeau et al., 2005). Thus, the ROC curve approach can be
used to facilitate decision making about the selection criteria
used for computational screening.
Computational protocols were designed and optimized for
both structure- and ligand-based vHTS workflows according to
the ROC curve method described previously (Triballeau et al.,
2005; see Figure S1 and Supplemental Experimental Procedures
available online for details). The structure-based vHTS protocol
utilized a molecular model of the receptor 5.24 binding pocket
(Luu et al., 2004). For ligand-based vHTS, we used pharmaco-
phore modeling to identify compounds in chemical space that
share characteristics similar to known receptor 5.24 ligands
(Speca et al., 1999). Our resulting pharmacophore model (Fig-
ure S2) comprises features that are consistent with the confor-
mation and interaction of L-arginine docked in a structural model
of receptor 5.24 (Luu et al., 2004).
Chemical Library and vHTS Implementation
We used our vHTS protocols to screen a database representing
a compilation of 1.6 million commercially available compounds
(see Experimental Procedures). A series of computational filters
(Triballeau et al., 2005) was applied to the database prior to
implementation of the vHTS workflows to reduce the number
of candidates to 758 unique chemical structures (see Supple-
mental Data for details). Screening the 758 compounds using
our vHTS protocols for receptor 5.24 resulted in 468 compounds
that satisfied our selection criterion in the structure-based proto-
col and 50 compounds that met our criterion in the ligand-based
protocol. Forty-six compounds are common to both lists (‘‘com-
mon hits’’), and include L-amino acids known to activate the
receptor. The vHTS workflow and results are summarized in
Table 1 and Figure S3.
Functional Validation of Compounds Identified by vHTS
We reasoned that chemical structures identified by two indepen-
dent approaches should comprise the most promising candi-
dates for subsequent validation by functional assays. Thus, we
focused mainly on compounds that were retained in common













Docking only 422 7 3
Common virtual hits 46 36 16
Pharmacophore only 4 2 0
Total 472 45 19
a A compound was operationally defined as active if it elicited R40%
maximum receptor activity at 20 mM.768 Neuron 60, 767–774, December 11, 2008 ª2008 Elsevier Inc.
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Novel Odorants Identified by Virtual Screeningby both screening protocols. Compounds were functionally
validated by screening for activation of receptor 5.24 expressed
in HEK293 cells, using a calcium mobilization assay in 96-well
plates. Chemicals were screened at 20 mM, a concentration
10 times higher than the EC50 for the receptor’s most potent
natural agonists, lysine and arginine (EC50 = 2 mM). We rea-
soned that only those compounds showing significant activity
at this concentration would be viable candidates as high affinity
agonists. Thirty-six compounds were initially tested from the
common hit list. After examining the structures of the most active
compounds identified in this preliminary functional screen (Table
2), we selected additional compounds from the structure-based
(seven compounds) or ligand-based (two compounds) vHTS hit
lists, as well as a few structural analogs of the top hits. Altogether
54 compounds were tested, with 45 from the three vHTS hit lists
(Figure S4; Tables 1, 2, and S1). Forty-two percent (19/45) of the
compounds tested from the vHTS hit lists showed significant
activity at 20 mM (operationally defined asR40% maximum ac-
tivity), which is remarkable given the more typical validation rate
of 10% or less in such screening protocols (Augen, 2002; Tribal-
leau et al., 2005, 2006). In addition, of the nine compounds
selected based on their structural similarities to the active com-
pounds, five exhibited significant activity as receptor 5.24 ago-
nists. We next generated dose-response curves to calculate
EC50 values for the 24 validated compounds (Tables 2 and S1).
Structure-Activity Analysis of vHTS Hits Reveals
a Strong Preference for Amino Acid Ligands
with Unbranched Side Chains
Our previous molecular modeling study of receptor 5.24 pre-
dicted interactions between specific residues and contact sites
on the bound ligand’s glycine core (the so-called proximal bind-
ing pocket) as well as on the ligand’s side chain (the ‘‘distal’’
binding pocket) (Luu et al., 2004). It is striking that all vHTS hits
that were validated as active compounds are linear amino acids
with no substitutions at the b and g positions (Table S1). This
characteristic probably reflects the restricted steric tolerance
of the residues interacting with this portion of the side chain, ser-
ine-151 (S151) on lobe 1 and asparagine-310 (N310) on lobe 2.
From our three-dimensional model of receptor 5.24, the bound
Table 2. Activities of the Top Five vHTS Hits and Known Natural Agonists
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aQ = glutamine derivative; K/R = lysine/arginine derivative; diAA = di-amino acid.
bReceptor activation assay was performed with a mixture of LL, DL, and DD isomers.Neuron 60, 767–774, December 11, 2008 ª2008 Elsevier Inc. 769
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Novel Odorants Identified by Virtual Screeningligand’s side chain’s b and g methylenes are in Van der Waals
contact with S151 and N310 (Luu et al., 2004) (Figure S5). These
contacts would preclude substitutions on the ligand’s side chain
and explain why, for example, phenylalanine, tyrosine, trypto-
phan, and their derivatives are poor agonists of receptor 5.24.
Molecular Determinants of LigandBinding andReceptor
Activation Revealed by Top vHTS Hits
The identification of novel high-potency agonists provides an op-
portunity to probe the molecular interactions underlying ligand
recognition and receptor activation. A close look at the side
chains of the most active molecules among the hits identified
by both the docking and pharmacophore models allowed us to
classify them into three groups: lysine/arginine-like (hit #’s 244,
48, 677), glutamine-like (hit #’s 338, 506, 586, 137, 583), and
di-amino acids (hit #’s 380, 299, 565, 611, 652, 479) (Tables 2
and S1). Most of the other validated hits (identified by the dock-
ing model alone or selected based on structural similarity to
some of the top hits) belong to one of these three categories
(Table S1). To gain insight into the interactions underlying the
properties of these novel receptor agonists, we generated mo-
lecular models of receptor 5.24 bound to selected compounds
from the three groups of chemicals.
Lysine/Arginine Analogs
In the lysine- and arginine-like series, substitution of a methylene
group with an oxygen atom in the alkyl chain of lysine (L-oxaly-
sine, hit # 244) or arginine (L-canavanine, hit # 677) results in
an 2-fold increase in ligand potency (Table 2). The interactions
with the ligands’ terminal amino (oxalysine) or guanidinium (can-
avanine) groups (Figures 1A and 1B) are similar to those pre-
dicted for lysine and arginine, respectively (Luu et al., 2004). In
addition, each analog’s oxygen heteroatom may provide polar
interactions with a cluster of serine residues in lobe 1 (S111,
S150, S151), which would explain the increased activity of oxa-
lysine and canavanine relative to lysine and arginine, respectively
(Figures 1A and 1B). Analogs containing sulfur heteroatoms at
these positions might be expected to have a similar (but weaker)
effect on ligand potency. Indeed, L-4-thialysine, which contains
a sulfur heteroatom in place of the oxygen heteroatom of L-oxa-
lysine, was retained by the structure-based vHTS protocol but
with a lower score than L-oxalysine and therefore not selected
for further study (data not shown). Restricting the flexibility of
the alkyl chain to favor the extended bioactive conformation as
in K1 or D425 does not significantly enhance the potency of
the arginine- and lysine-like ligands (Table S1).
Di-amino Acids
The strongest activation in this class was observed with hit # 380
(L-cystathionine; EC50 = 1.7 mM) and hit # 299 (LL- and DL-a,b-
diaminopimelic acid; EC50 = 2.4 mM for a mixture of LL, DL,
and DD enantiomers) (Table 2). Docking of L-cystathionine in
a structural model of receptor 5.24 suggests ligand-receptor in-
teractions with the distal carboxylate in addition to interactions
with the distal amino group similar to those predicted for L-lysine
or L-oxalysine (compare Figures 1A and 1C). In contrast, docking
Figure 1. Molecular Models of Selected
vHTS Hits Docked in the Receptor 5.24
Binding Pocket
Lysine and arginine analogs: (A) L-oxalysine (hit #
244) and (B) L-canavanine (hit # 677); di-amino
acids: (C) L-cystathionine (hit # 380) and (D) LL-
a,3-diaminopimelic acid (hit # 299); glutamine
and glutamine analogs: (E) L-glutamine and (F)
L-glutamic acid-g-p-nitroanilide (hit # 338). Com-
pounds were computationally docked in the re-
ceptor 5.24 binding pocket. For clarity, only distal
binding pocket residues are shown (thin lines); in
(E) and (F), far distal lobe 1 residues are displayed
in blue, amide binding residues are shown in
purple, and residues highlighted in yellow com-
prise a hydrophobic ring proposed previously
(Luu et al., 2004). Carbon atoms are depicted in
gray, oxygens in red, nitrogens in blue, sulphurs
in yellow, and hydrogens in white (hydrogens
shown only on ligands). Predicted hydrogen
bonds are displayed as dashed green lines. Novel
receptor-ligand interactions with the oxygen het-
eroatoms of oxalysine and canavanine as com-
pared to their natural amino acid counterparts
(lysine and arginine, respectively) are noted with
green arrowheads (A and B). Note the different
binding of each di-amino acid’s distal carboxylate
to distal pocket residues (far right of [C] and [D]).
Comparison of the dockings in (E) and (F) reveals
the participation of L-glutamic acid-g-p-nitroani-
lide’s nitro substituent in a distal hydrogen bond
network, which may explain this ligand’s en-
hanced potency relative to glutamine.770 Neuron 60, 767–774, December 11, 2008 ª2008 Elsevier Inc.
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of the distal binding pocket interactions in order to accommo-
date the distal acidic group of this di-amino acid in either diaste-
reoisomeric configuration (the LL isomer is shown in Figure 1D).
The docking model also predicts hydrogen bonds with the sulfur
heteroatom of L-cystathionine (Figure 1C), as seen with the oxy-
gen heteroatoms in the oxalysine and canavanine side chains
(Figures 1A and 1B). However, when the adjacent d-CH2 group
of L-cystathionine is replaced by a sulfur atom (hit # 479) or
selenium atom (hit # 443), the potency is markedly decreased
(Table S1).
Glutamine Analogs
While glutamine displays modest potency (EC50 = 9.7 mM), we
discovered that its N-4-nitrophenyl derivative, L-glutamic acid-
g-p-nitroanilide (hit # 338; EC50 = 0.72 mM) is over 10 times
more potent than L-glutamine and 2- to 3-fold more potent
than lysine or arginine, the two most potent natural amino acid
ligands of receptor 5.24 (Luu et al., 2004; Speca et al., 1999).
This enhanced potency derives mainly from the nitro moiety,
as the N-phenyl glutamine analog (compound Q2, EC50 =
7.9 mM for the racemic mixture) is only slightly more potent
than L-glutamine. None of the other substitutions of the phenyl
ring or polar N substituents such as -NH2 or -OH, induce a similar
increase in potency (e.g., hit #’s 506, 583, 588, and compounds
Q1 and Q3; Table S1). Several factors may be responsible for the
enhanced potency of L-glutamic acid-g-p-nitroanilide. From
molecular modeling, we predict that in addition to making similar
contacts as bound glutamine (Figure 1E), the distal nitro group
participates in a set of novel polar interactions with Q78 and
D388 in the distal pocket (Figure 1F). The distal nitro moiety
may also constrain the conformation of L-glutamic acid-g-p-ni-
troanilide’s phenyl ring to allow optimal interaction with M389
(and possibly other hydrophobic residues in the vicinity), which
we previously demonstrated to be critical for activation by
high-affinity ligands (Luu et al., 2004).
Identification of a Ligand-Mediated Helix-Helix
Interaction Conserved in Divergent Amino Acid
Receptors
Among the residues predicted to contact the distal nitrophenyl
moiety of L-glutamic acid-g-p-nitroanilide (Figure 1F), K74,
Q78, D388, and M389 are located within helices aI and
aIX. These two helices comprise part of a conserved lobe
1 core structure in all proteins belonging to the structural peri-
plasmic binding protein-like I superfamily, which includes the
mGlu receptors and bacterial amino acid binding proteins
such as LIVBP, as well as receptor 5.24 (Luu et al., 2004;
Figure 2A). From the crystal structures of mGlu1 (PDB code
1ewk) and LIVBP (PDB code 1z16), coordination of ligand by
these two helices relies upon interactions with residues at
positions corresponding to Q78 and M389 in receptor 5.24
(highlighted in Figure 2A). In mGlu1, bound glutamate forms
a bridge between the two helices via ionic interactions with
R78 on helix aI (via a bridging water molecule) and K409 on
helix aIX (Figure 2B). Similarly, in LIVBP, the hydrophobic
side chain of bound leucine interacts with Y18 (helix aI) and
F256 (helix aIX), drawing the two helices in close apposition
(Figure 2C).
Whereas bound L-arginine is not predicted to interact directly
with residues on helix aI (although hydrogen bonding may
occur between Q78 on helix aI and D388 on helix aIX; Fig-
ure 2D), our model predicts that bound L-glutamic acid-g-
p-nitroanilide forms a bridge between these two helices via an
novel interaction with Q78 in helix aI and hydrophobic interac-
tions with M389 (as well as polar interactions with D388) in helix
aIX (Figure 2E). It is remarkable that, although the amino acid
residues in mGlu1, LIVBP and receptor 5.24 are divergent at
positions 78 and 389 (receptor 5.24 coordinates; Figure 2A),
the function of these sites in conferring both affinity and selec-
tivity appears to have been conserved in these amino acid
binding proteins.
Figure 2. Conservation of Agonist-Helix In-
teractions in the LIVBP-like Family of Amino
Acid Binding Proteins
(A) Sequence alignment of helices aI and aIX (red)
of the LIVBP, mGlu1, and receptor 5.24 binding
pockets. Residues participating in ligand-helix
bridging interactions are highlighted in gray.
(B) Crystal structure of L-glutamate bound to
mGlu1 (PDB code 1ewk) reveals coordination of
the ligand’s terminal carboxylate by R78 (helix aI)
and K409 (helix aIX).
(C) Crystal structure of L-leucine bound to LIVBP
(PDB code 1z16) similarly shows hydrophobic in-
teractions between the bound ligand’s side chain
and Y18 (helix aI) and F276 (helix aIX).
(D) Molecular modeling of L-arginine docked in
a three-dimensional model of the receptor 5.24
binding pocket predicts interactions of the
ligand’s side chain with M389 and D388 in helix
aIX, but not with residues in helix aI.
(E) By contrast, the terminal nitro substituent of
L-glutamic acid-g-p-nitroanilide (hit 338) is pre-
dicted to interact via hydrogen bonding with Q78 (helix aI) and D388 (helix aIX). A hydrophobic interaction is also predicted between the ligand’s phenyl ring
and M389 (helix aIX). In addition, an orthogonal interaction (Paulini et al., 2005) may occur between the distal nitro group and D388. Polar interactions are depicted
by dashed green lines (small red sphere in [B] represents a bridging water molecule); hydrophobic contacts are shown as transparent gray spheres.Neuron 60, 767–774, December 11, 2008 ª2008 Elsevier Inc. 771
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In Vivo
The data presented thus far demonstrate the utility of our vHTS
approach in identifying novel molecules that can be used to
probe the structure and function of the receptor 5.24 ligand bind-
ing pocket. We next wished to determine whether agonists iden-
tified in this way—i.e., based on their interactions with a specific
receptor—could also function as odorants by eliciting responses
in olfactory sensory neurons. Candidate compounds were tested
for activity in vivo by measuring evoked changes in voltage
across the goldfish olfactory epithelium. This measurement,
known as the electro-olfactogram (EOG; Ottoson, 1956), is an
extracellular field potential that locally summates the activity of
a population of cells in the sensory epithelium and is widely
used as a reliable assay for olfactory neuron responses ina variety
of vertebrates, including fish (Scott and Scott-Johnson, 2002).
We selected four of the top vHTS hits (# 338, L-glutamic acid
g-p-nitroanilide; # 244, oxalysine; # 299, diaminopimelic acid;
and # 677, L-canavanine) for testing by EOG in the goldfish olfac-
tory epithelium. As shown by the representative traces in Fig-
ure 3, all compounds elicited robust EOG responses at 105 M,
showing peak EOG amplitudes comparable to the response
generated by 105 M L-arginine. Testing of L-glutamic acid
g-p-nitroanilide, L-oxalysine, diaminopimelic acid, and L-argi-
nine over a wide concentration range revealed detectable
responses at 108 M (Table S2). The responses did not show
saturation at 104 M, which is typical of amino acid-evoked
EOGs in fish (Byrd and Caprio, 1982; Rolen et al., 2003) and
probably reflects the recruitment of low-affinity receptor interac-
tions at higher ligand concentrations.
Interestingly, whereas L-glutamic acid g-p-nitroanilide and
L-oxalysine exhibit higher apparent affinities to receptor 5.24
than L-arginine (Table 2), in vivo they elicit somewhat lower
peak responses across all concentrations tested (Table S2). A
possible explanation for this observation is that L-glutamic
acid g-p-nitroanilide and L-oxalysine interact with a smaller
number of receptors than L-arginine (i.e., they are more specific).
On the other hand, diaminopimelic acid and L-canavanine are
slightly more potent than L-arginine in vivo, suggesting that their
interactions with the population of receptors expressed in the
olfactory epithelium may be more promiscuous than those of
the other compounds (including L-arginine). Whatever the
case, EOG recordings clearly demonstrate that the top hits iden-
tified by our receptor 5.24-based computational screening para-
digm can indeed function as odorants in vivo.
DISCUSSION
In the present study, we applied a computational high-through-
put screening approach to discover new agonists of receptor
5.24, an olfactory C family GPCR. Our strategy utilized ligand-
based and structure-based models that together identified sev-
eral agonists showing higher potency than any of the receptor’s
previously identified natural ligands. Interestingly, compounds
that bind to lobe 1 of an mGlu receptor but prevent closure of
the VFTD are antagonists (Bessis et al., 2002). It therefore may
be possible to identify receptor 5.24 antagonists by screening
for compounds that fit a structural model of the receptor’s ligand
binding domain in the open, but not closed conformation. More
broadly, our vHTS approach should be applicable to the identifi-
cation of ligands for other chemosensory C family GPCRs (the
V2R/V2R-like vomeronasal/olfactory receptors and T1R taste
receptors) (Alioto and Ngai, 2006; Shi and Zhang, 2007) as well
as the OR family olfactory receptors, whose transmembrane li-
gand binding domains have been characterized using molecular
modeling techniques (Abaffy et al., 2007; Katada et al., 2005;
Schmiedeberg et al., 2007).
Conservation of Molecular Determinants Underlying
Ligand Recognition in the Amino Acid Receptors:
Functional Implications
L-glutamic acid-g-p-nitroanilide is the most potent agonist iden-
tified in this screen. We attribute the enhanced potency of this
compound to novel interactions between its distal nitrophenyl
moiety and sites on helices aI and aIX of the ligand binding do-
main. Significantly, the positions of these determinants on heli-
ces aI and aIX—and their role in dictating affinity and selectiv-
ity—appear to be a conserved feature of highly divergent
amino acid receptors, including bacterial LIVBP and a mamma-
lian mGlu receptor (Figure 2). In this regard it is interesting that,
among the top 5 vHTS hits, L-glutamic acid-g-p-nitroanilide—
a nonnatural amino acid—is the only compound predicted to
form direct bridging interactions with helices aI and aIX. The con-
served role of these contact sites in receptor 5.24 suggests the
existence of naturally occurring high potency ligands that partic-
ipate in similar ligand-receptor interactions.
Receptor-Based Computational Screening
as a Tool for the Discovery of Novel Odorants
Electrophysiological recordings from goldfish olfactory epithe-
lium confirmed that at least four of the compounds identified
Figure 3. Compounds Identified by vHTS Function as Odorants In Vivo
Electro-olfactogram (EOG) recordings were performed on goldfish olfactory epithelium to measure olfactory responses to L-arginine and selected top vHTS hits.
Representative traces are shown in which each compound was applied at 105 M concentration. Each compound elicited a negative potential characteristic of an
excitatory olfactory neuronal response. H20, water control; L-Arg, L-arginine; 338, L-glutamic acid-g-p-nitroanilide; 244, L-oxalysine; 299, diaminopimelic acid;
677, L-canavanine.772 Neuron 60, 767–774, December 11, 2008 ª2008 Elsevier Inc.
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odorants in vivo. These results validate the overall approach of
using a receptor-specific model as a starting point in the search
for novel odorants. Interestingly, one compound identified in our
screen, diaminopimelic acid, is a component of Gram-negative
bacterial cell walls and an intermediate in the bacterial biosyn-
thetic pathways for lysine and peptidoglycans (Born and Blan-
chard, 1999; Work, 1950). Moreover, the two natural stereoiso-
mers of diaminopimelic acid (LL and DL) can be found in
estuaries at concentrations ranging from 10 to 100 nM
(Jorgensen et al., 2003), well within the sensitivity of the goldfish
olfactory system for this chemical. We speculate that, as fish are
thought to use metabolites such as amino acids and nucleotides
as feeding cues (Hara, 1994), diaminopimelic acid may signal
through the olfactory system the presence of bacteria, which
presumably would be localized at or near potential food sources.
Application of the high-throughput computational screening de-
scribed here to other olfactory and taste receptors may reveal
additional natural products that function as chemosensory cues.
EXPERIMENTAL PROCEDURES
vHTS
Computational protocols were designed for both ligand-based and structure-
based screening workflows using the ROC curve method (Triballeau et al.,
2005). These protocols were used to screen the 1.6 million compound CAP
database (version 2004, Accelrys Inc.) following a computational prefiltering
of the database. Details of the vHTS workflows are described in the Supple-
mental Data.
Molecular Modeling with Active Compounds
Selected compounds from the vHTS hit lists, as well as structural analogs,
were subjected to computational docking in a molecular model of the receptor
5.24 ligand binding domain, as described previously (Bertrand et al., 2002; Luu
et al., 2004).
Receptor Activation Assays
For cell-based receptor activation assays, receptor 5.24 was expressed in
HEK293 cells using a CMV expression vector (Luu et al., 2004; Speca et al.,
1999). Receptor activation was assayed by measuring changes in intracellular
calcium using a Flexstation II fluorescence plate reader (Molecular Devices).
Details of these procedures can be found in the Supplemental Data.
Electro-olfactogram Recordings
EOG recordings on goldfish olfactory epithelium were carried out essentially
as described previously (Irvine and Sorensen, 1993). Odors were applied for
5 s with a minimum interstimulus interval of 3 min to allow the olfactory epithe-
lium to recover full responsiveness. For each fish, a compound was tested
2–3 times and an average response was computed. The per-fish averaged re-
sponses were then normalized to the response elicited by a reference standard
odorant, 105 M L-arginine. Responses to the reference standard were mea-
sured at least every 45 min and bracketed the trials with each test odorant.
Normalized responses from 3–4 fish were then averaged, resulting in a mean
normalized response for each compound/concentration tested. All stimuli
were tested on every fish in this study.
SUPPLEMENTAL DATA
The Supplemental Data include five figures, two tables, and Supplemental
Experimental Procedures and can be found with this article online at http://
www.neuron.org/supplemental/S0896-6273(08)00968-9.
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